Photo of Byron B. Kirkland

Byron B. Kirkland

Managing Partner
AA Contact Info

Debbie Jolley
Phone: 919.821.6744


A corporate and securities lawyer for over 30 years, Byron Kirkland has extensive experience in private equity and venture capital transactions; domestic and international mergers and acquisitions; and general corporate law and securities matters. He represents emerging and established companies, both privately and publicly held, across diverse industry sectors including information technology, clean technology, medical device, biotechnology, pharmaceutical services, communications and manufacturing. Byron regularly advises clients with regard to general business, capital-raising financing and commercial law matters. 

Byron also has an active venture capital and private equity fund practice, representing venture capital and private equity funds. He regularly assists funds with their portfolio company investments, acquisitions and fund formation matters.

Byron was named Managing Partner in January 2020 and is a member of the firm's Management Committee.

  • American Bar Association
    • Past Member, Business Law Section Council
  • Fellow, American Bar Foundation
  • American Counsel Association
  • North Carolina Bar Association
    • Past Chair, Young Lawyers Division
    • Past Chair, Securities Regulation Committee
  • Director, Board of Directors, NC TECH (North Carolina Technology Association)
  • Director, Board of Directors, The Miracle League of the Triangle, Inc.
  • Director, Board of Directors, United Way of the Greater Triangle
  • Wake County Bar Association
  • Past Member, Board of Visitors, University of North Carolina at Chapel Hill
  • Past Member, Board of Directors, Council for Entrepreneurial Development
  • Triangle Business Journal "CEO of the Year" Honoree (2021)
  • Best Lawyers®, "Lawyer of the Year," Raleigh Securities/Capital Markets Law (2011, 2016), Raleigh Mergers & Acquisitions Law (2013, 2018, 2022)
  • Best Lawyers®, Corporate Law, Mergers & Acquisitions Law, Securities/Capital Markets Law, Venture Capital Law (2007-2022), Leveraged Buy Outs & Private Equity Law (2022)
  • Chambers USA: America’s Leading Business Lawyers, Corporate/M&A (2004-2021)
  • North Carolina Super Lawyers (2006-2019)
  • IFLR1000: The Guide to the World's Leading Financial Law Firms, "Highly Regarded," M&A (2018-2021) 
  • Business North Carolina Legal Elite, Business (2013)
  • Martindale-Hubbell AV Preeminent Rated



  • Advised a contract research organization in a definitive agreement to acquire a specialized contract research organization for the biotechnology industry.
  • Advised a specialty pharmaceutical company in its acquisition of a private pharmaceutical company focusing on pediatric medications.
  • Advised a private equity fund and its contract research solutions portfolio company in their acquisition of a statistical programming, consulting, and data management company.
  • Represented affiliated multidisciplinary engineering, investigation and construction companies in a sale of assets process involving multiple potential buyers, culminating in the sale of substantially all of their assets to a wireless network services company.  
  • Represented a publicly traded company and leading provider of end-to-end spend management solutions in its sale of the company to a leading technology-focused private equity firm for approximately $509 million.
  • Advised a family office in a definitive agreement to purchase the outstanding equity interests of the largest independent blender and packager of lubricants to the automotive, agriculture, commercial and heavy duty markets in North America. 
  • Represented privately held distributor and supplier of original automotive equipment and aftermarket replacement products in its merger with a publicly traded leading provider of automotive aftermarket parts and accessories in a transaction valued at $2.04 billion.
  • Represented several venture capital and private equity funds in their fund formations. 
  • Represented a university in spinning out its investment office to form a new outsourced asset management company. 
  • Represented a SaaS company in a merger with a data integration publicly held company. 
  • Advised a private equity fund in its acquisition of a specialty pharmaceutical company.
  • Advised a global supplier of chemical and slurry delivery equipment in an agreement to sell all of its issued and outstanding common stock to a process and mechanical contractor.
  • Advised an emerging biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products in its acquisition of substantially all of the assets of a biotechnology company, including its high-throughput bacteriophage (“phage”) discovery platform.

News & Publications


Bar & Court Admissions

  • North Carolina


University of North Carolina, J.D., with honors, 1987

University of North Carolina, M.B.A., 1987

University of North Carolina, B.A., 1983

Lawyer Directory
Back to Page